Water Companies

Debate between Jeremy Hunt and Emma Hardy

Monday 8th June 2026 Commons Chamber

[Emma Hardy]

I thank my hon. Friend, who continues to be a formidable, incredibly impressive campaigner, as she was through her work on the Environment, Food and Rural Committee; honestly, she has been amazing. We have set out our White Paper, and a transparent process will look at whether a new model will go ahead. As the Secretary of State has also said, I have always been in favour of mutuals, and I do not have a problem with not-for-profits, but we need a clear look at the process to see whether that would be in the best interests of customers before any change goes ahead.

[Sir Jeremy Hunt (Godalming and Ash) (Con)]

Is not the root problem a profound failure of regulation over the last 25 years, for which Labour, the Conservatives and the Lib Dems all bear responsibility? We have regulated for lower prices and more investment, but we have not stopped companies from loading up their balance sheets with debt, which means higher prices and less investment. I am not a believer in nationalisation, because I know from having been Chancellor that the state will never find the £104 billion now promised by the private sector, but if we are to stick with private companies, do we not need to regulate differently so that we have lower prices and more investment?

[Emma Hardy]

I thank the right hon. Gentleman for his question—it still feels slightly odd to be on the opposite side of this, with him questioning me. I will gently say that, yes, I do accept the premise of his question—we need tougher and more effective regulation, because the regulation system has failed—but I would have thought that, as the second most powerful person in the previous Government, he might have had an opportunity to act himself.

Oral Answers to Questions

Debate between Jeremy Hunt and Emma Hardy

Thursday 6th February 2025 Commons Chamber

[Emma Hardy]

I thank my hon. Friend, who is right to highlight how the previous flooding formula discriminated against rural communities because it was based purely on the number of properties protected, not on creating the right solution in the right area. That is exactly why we wish to reform the formula, and we will be announcing a consultation very shortly.

[Jeremy Hunt (Godalming and Ash) (Con)]

Given that the Office for Budget Responsibility refused to endorse the £22 billion black hole figure—in fact, it refused to say that there was any black hole at all—will the Secretary of State tell the House what possible justification there can be for the removal of agricultural property relief, which will do untold damage to the growth prospects of family farms in my constituency and across the country?

Oral Answers to Questions

Debate between Jeremy Hunt and Emma Hardy

Tuesday 20th June 2023 Commons Chamber

[Emma Hardy (Kingston upon Hull West and Hessle) (Lab)]

Ever-increasing food prices mean that some families are having to cut down on the amount they eat. Will the Minister support Labour’s plan to negotiate a new veterinary agreement for agriculture products to reduce the cost for food producers and bring down those crippling food prices?

[Jeremy Hunt]

We will always look at Labour policies, but they are normally not right.

Economic Update

Debate between Jeremy Hunt and Emma Hardy

Monday 17th October 2022 Commons Chamber

[Jeremy Hunt]

There is the problem, with all the noise from the Opposition. This compassionate Conservative Government were able to step in with massive help for members of the public, with the furlough scheme and the energy price guarantee, because we took difficult decisions on the economy in the preceding years, each and every one of which was opposed by the Labour party. I say to my right hon. Friend that the point of a Conservative Government is to build a strong economy, and that is what we will do. It is the job—[Interruption.] This is an important point that I wish to make. It is the job of the Chancellor not just to balance the books but to have a vision for economic growth, and I hope I will persuade my right hon. Friend in two weeks’ time that I have just that vision.

[Emma Hardy (Kingston upon Hull West and Hessle) (Lab)]

Does the Chancellor agree with the Prime Minister, who confirmed that the state pension would rise with inflation in April? If he does agree with her, can he commit himself to that today?

[Jeremy Hunt]

I am very aware of how many vulnerable pensioners there are, and of the importance of the triple lock. As I said earlier, I am not making any commitments on any individual policy areas, but every decision we take will be taken through the prism of what matters most to the most vulnerable.

Medicines and Medical Devices Safety Review

Debate between Jeremy Hunt and Emma Hardy

Wednesday 21st February 2018 Commons Chamber

[Mr Hunt]

I very much hope so, and the crucial point that has come out from the contributions of Members in all parts of the House is that the processes we have had in place to date have not had the confidence of the families affected. That applies to a whole range of issues, and I believe medicine is changing fundamentally: people who are passionate about medical innovation and life sciences know that we need to have a very close partnership with patients in order to make proper advances. But we have not always got this right, and that is what I hope Baroness Cumberlege’s review will help us to do.

[Emma Hardy (Kingston upon Hull West and Hessle) (Lab)]

I welcome the audit on vaginal mesh and the promised register, but there are a couple of things I want to raise. One is support for victims. My constituent Angie was referred from Hull to Manchester to see somebody, and has now been told she will have to wait months before anybody can properly analyse what has happened to her, so can more resource be given to help the victims of vaginal mesh? Also, will the Secretary of State look into the licensing process on how these things get into the market and are put out there for use by surgeons? Finally, we should not just look at training, because it is not just about the training for how we put these things in; I believe that the product itself is faulty.

[Mr Hunt]

We will certainly look at all those things, and the hon. Lady is absolutely right to draw attention to them. Licensing is one thing, but it is also important to ensure that proper information is available to clinicians and patients, because it appears from these cases that there are a number of drugs and devices that are safe but only in certain circumstances, and that knowledge might not have been properly disseminated. The database that the hon. Lady mentioned will help us to get that right.